LBA98 Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial

Bibliographic Details
Title: LBA98 Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial
Authors: Proto, C., Manglaviti, S., Galli, G., Imbimbo, M., Alvisi, M.F., Zollo, F., Perrino, M.R.A., Giuliano, M., Pietroluongo, E., Ballatore, Z., Chella, A., Fabbri, A., Vigorito, R., De Braud, F.G.M., Pasello, G., Petrini, I., Berardi, R., Zucali, P.A., Ganzinelli, M., Garassino, M.C., Lo Russo, G.
Source: In Annals of Oncology October 2023 34 Supplement 2:S1337-S1337
Database: ScienceDirect
More Details
ISSN:09237534
DOI:10.1016/j.annonc.2023.10.101
Published in:Annals of Oncology
Language:English